Bioengineering pioneer Genomatica has raised $90 million in private funding to accelerate the commercialization of two chemicals it has developed from renewable sources-chemicals that are being used today in plastics, cosmetics, and personal care. The company says it will also use the money to further ongoing development of a third chemical, to be used in sustainable nylon.
A new investor, New York-based investment firm Casdin Capital, led the financing, Genomatica announced Wednesday. Previous investors also participated in the round, including Genomatica’s largest shareholder, Connecticut-based hedge fund Viking Global Investors, and Ginkgo Bioworks, a venture-backed synthetic biology company in Boston. Ginkgo,… Read more »
UNDERWRITERS AND PARTNERS